Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031

The veterinary contract manufacturing & research market is expected to grow from USD 6.38 billion in 2026 to USD 9.24 billion by 2031, at a CAGR of 7.7%. The market growth is driven by several key factors shaping the future of veterinary drug development, biologics manufacturing, and precision animal health.

A major driver of this growth is the increasing demand for outsourced development and manufacturing services as animal health companies seek to accelerate product pipelines, reduce internal costs, and access specialized expertise for complex therapeutics such as biologics, vaccines, and advanced formulations. As the veterinary industry shifts toward more targeted, data-driven treatment approaches, the need for high-quality research, analytical testing, and GMP-compliant production is rapidly rising. Additionally, the growing burden of chronic, infectious, and zoonotic diseases in both companion and livestock animals is driving demand for faster and more efficient research and development (R&D) processes. CDMOs and CROs play a critical role in meeting this need by providing scalable manufacturing, high-throughput screening, and advanced study capabilities. The ongoing trend toward modernization in veterinary healthcare, including the adoption of real-time monitoring tools, digital workflows, and improved clinical trial management, further strengthens reliance on specialized outsourcing partners.

Technological advancements, including the integration of AI for predictive modeling, automation in bioprocessing, and the development of enhanced analytical platforms, also drive market growth. These innovations enhance accuracy, shorten development timelines, and expand the applications of outsourced services across preclinical, clinical, and commercial phases. Overall, rising industry demands, advancements in technology, and the growing shift toward specialized and outsourced expertise are driving strong and sustained growth in the veterinary contract manufacturing & research market.

“By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.”

The software & services segment is expected to see the highest growth in the veterinary contract manufacturing & research market, due to rising pet ownership, increasing spending on advanced treatments, and growing demand for innovative therapeutics for dogs and cats. Conditions such as cancer, obesity, allergies, and chronic diseases are becoming more prevalent in pets, driving the need for new drugs, biologics, and specialty formulations. Pet owners’ willingness to invest in premium care, coupled with the humanization of pets and expanding insurance coverage, is encouraging animal health companies to develop more complex products—leading to greater outsourcing of R&D, manufacturing, and clinical studies to CDMOs and CROs.

“By end user, the multinational animal-health companies segment accounted for the largest market share in 2024.”

In 2024, the veterinary clinics segment dominated the veterinary contract manufacturing & research market because they manage extensive product pipelines, operate globally regulated supply chains, and consistently invest in developing advanced therapeutics, vaccines, and diagnostics. Their broad portfolios and high production volumes create a strong need for specialized outsourcing partners to support formulation, scale-up, analytical testing, and clinical research. Additionally, these companies increasingly rely on CDMOs and CROs to accelerate time-to-market, expand manufacturing capacity, and access cutting-edge technologies, making them the primary contributors to overall market demand.

“The Asia Pacific region is projected to witness the highest growth rate during the forecast period.”

The Asia Pacific is expected to experience the highest growth in the veterinary contract manufacturing & research market, driven by rising livestock production, increasing pet ownership, and growing investment in animal health infrastructure across countries such as China, India, and Southeast Asia. The region is witnessing rapid expansion of veterinary pharmaceutical manufacturing, greater adoption of advanced biologics and diagnostics, and stronger government support for disease control and vaccination programs. Additionally, lower operational costs, improving regulatory frameworks, and the emergence of local CDMOs and CROs are attracting global animal health companies to outsource more research and manufacturing to APAC, driving its accelerated growth.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
• By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Multinational animal-health companies (59%), mid-sized / specialty animal-health firms (26%), and start-ups & veterinary biotech firms (15%)
• By Designation: R&D directors/heads of research (47%), product development & innovation managers (22%), regulatory affairs managers/directors (15%), and others (16%)
• By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the veterinary contract manufacturing & research market in various segments. It aims to estimate the market size and growth potential of this market by service, product type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

• Analysis of key drivers (growth in animal health spending, increasing complexity of veterinary biologics and the increasing regulatory burden for GMP, biosecurity & environmental compliance.), restraints (limited specialized infrastructure and long approval timelines & regulatory diversity globally), opportunities (geographic expansion into emerging markets, digital CRO services), and challenges (difficulty in clinical trial recruitment and difficulty in scaling sterile/biologics capacity quickly) influencing the growth of the veterinary contract manufacturing & research market
• Product Development/Innovation: Detailed insights on upcoming technologies and service launches in the veterinary contract manufacturing & research market
• Market Development: Comprehensive information about lucrative emerging markets; the report analyzes the markets for various types of veterinary CDMO & CRO services across regions
• Market Diversification: Exhaustive information about services, untapped regions, recent developments, and investments in the veterinary contract manufacturing & research market
• Competitive Assessment: In-depth assessment of market shares, strategies, services, distribution networks, and manufacturing capabilities of the leading players in the veterinary contract manufacturing & research market

Show more